Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort

Open access
Kullmann, Friederike, Strissel, Pamela L, Strick, Reiner, Stoehr, Robert, Eckstein, Markus, Bertz, Simone, Wullich, Bernd, Sikic, Danijel, Wach, Sven, Taubert, Helge, Olbert, Peter, Heers, Hendrik, Lara, María Fernanda, Macias, Maria Luisa, Matas-Rico, Elisa, Lozano, Maria José, Prieto, Daniel, Hierro, Isabel, van Doeveren, Thomas, Bieche, Ivan, Masliah-Planchon, Julien, Beaurepere, Romane, Boormans, Joost L, Allory, Yves, Herrera-Imbroda, Bernardo, Hartmann, Arndt, Weyerer, Veronika · 2023 · Journal of Clinical Pathology

Abstract

Aims: Upper tract urothelial carcinoma (UTUC) is a rare malignancy with a poor prognosis which occurs sporadically or in few cases results from a genetic disorder called Lynch syndrome. Recently, examination of microsatellite instability (MSI) has gained importance as a biomarker: MSI tumours are associated with a better response to immunomodulative therapies. Limited data are known about the prevalence of MSI in UTUC. New detection methods using the fully automated Idylla MSI Assay facilitate analysis of increased patient numbers. Methods: We investigated the frequency of MSI in a multi-institutional cohort of 243 consecutively collected UTUC samples using standard methodology (Bethesda panel), along with immunohistochemistry of mismatch repair (MMR) proteins. The same tumour cohort was retested using the Idylla MSI Assay by Biocartis. Results: Using standard methodology, 230/243 tumours were detected as microsatellite stable (MSS), 4/243 tumours as MSI and 9/243 samples as invalid. In comparison, the Idylla MSI Assay identified four additional tumours as MSS, equalling 234/243 tumours; 4/243 were classified as MSI and only 5/243 cases as invalid. At the immunohistochemical level, MSI results were supported in all available cases with a loss in MMR proteins. The overall concordance between the standard and the Idylla MSI Assay was 98.35%. Time to result differed between 3 hours for Idylla MSI Assay and 2 days with the standard methodology. Conclusion: Our data indicate a low incidence rate of MSI tumours in patients with UTUC. Furthermore, our findings highlight that Idylla MSI Assay can be applied as an alternative method of MSI analysis for UTUC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jclinpath-2021-207855

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (A) Representative capillary electrophoresis results of MSI tumour of (a) normal tissue and (b) tumour tissue. X-axis is the number of bases; y-axis is the number of amplicons reflected in fluorescence intensity, scaled to the variable amount of analysed DNA. Blue, green and black peaks are products of the amplifications of the different MSI markers: BAT25, D2S123, BAT26, D17S250 and D5S346. Comparing (a) and (b), we saw a shift and extension of base amplification product in each marker of tumour tissue compared with normal tissue. (B) Representative capillary electrophoresis results of MSS tumour of (a) normal tissue and (b) tumour tissue. X-axis is the number of bases; y-axis is the number of amplicons reflected in fluorescence intensity, scaled to the variable amount of analysed DNA. Blue, green and black peaks are products of the amplifications of the different MSI markers: BAT25, D2S123, BAT26, D17S250 and D5S346. No shift and no expansion of the base amplification product are seen in the markers of tumour tissue (b) compared with normal tissue (a). MSI, microsatellite instability; MSS, microsatellite stable.
Figure 1 (A) Representative capillary electrophoresis results of MSI tumour of (a) normal tissue and (b) tumour tissue. X-axis is the number of bases; y-axis is the number of amplicons reflected in fluorescence intensity, scaled to the variable amount of analysed DNA. Blue, green and black peaks are products of the amplifications of the different MSI markers: BAT25, D2S123, BAT26, D17S250 and D5S346. Comparing (a) and (b), we saw a shift and extension of base amplification product in each marker of tumour tissue compared with normal tissue. (B) Representative capillary electrophoresis results of MSS tumour of (a) normal tissue and (b) tumour tissue. X-axis is the number of bases; y-axis is the number of amplicons reflected in fluorescence intensity, scaled to the variable amount of analysed DNA. Blue, green and black peaks are products of the amplifications of the different MSI markers: BAT25, D2S123, BAT26, D17S250 and D5S346. No shift and no expansion of the base amplification product are seen in the markers of tumour tissue (b) compared with normal tissue (a). MSI, microsatellite instability; MSS, microsatellite stable.CC BY-NC · PubMed Central
Figure 2 Whole slides of immunohistochemical staining of MMR-proteins MLH1, MSH2, MSH6 and PMS2. Note the strong staining of inflammatory and stromal cells and additionally the strong nuclear expression of tumour cells for MLH1 and PMS2. In contrast, immune and stromal cells are strongly stained (internal positive control), but the tumour cells are showing a nuclear loss of expression for MSH2 and MSH6. MLH1, mutL homologue 1; MMR, mismatch repair; MSH2, mutS homologue2; MSH6, mutS homologue 6; PMS2; PMS1 homologue 2.
Figure 2 Whole slides of immunohistochemical staining of MMR-proteins MLH1, MSH2, MSH6 and PMS2. Note the strong staining of inflammatory and stromal cells and additionally the strong nuclear expression of tumour cells for MLH1 and PMS2. In contrast, immune and stromal cells are strongly stained (internal positive control), but the tumour cells are showing a nuclear loss of expression for MSH2 and MSH6. MLH1, mutL homologue 1; MMR, mismatch repair; MSH2, mutS homologue2; MSH6, mutS homologue 6; PMS2; PMS1 homologue 2.CC BY-NC · PubMed Central
Figure 3 Comparison of workflow of (A) standard method and (B) Idylla MSI assay. FFPE, formalin-fixed paraffin-embedded; MSI, microsatellite instability.
Figure 3 Comparison of workflow of (A) standard method and (B) Idylla MSI assay. FFPE, formalin-fixed paraffin-embedded; MSI, microsatellite instability.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 22

Metadata

Authors
Kullmann, F., Strissel, P. L., Strick, R., Stoehr, R., Eckstein, M., Bertz, S., Wullich, B., Sikic, D., Wach, S., Taubert, H., Olbert, P., Heers, H., Lara, M. F., Macias, M. L., Matas-Rico, E., Lozano, M. J., Prieto, D., Hierro, I., van Doeveren, T., Bieche, I., Masliah-Planchon, J., Beaurepere, R., Boormans, J. L., Allory, Y., Herrera-Imbroda, B., Hartmann, A., & Weyerer, V.
Affiliations
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Brixsana Private Clinic (IT)
  • Universitätsklinikum Gießen und Marburg (DE)
  • Department of Urology, Virgen de la Victoria University Hospital Málaga, Instituto de Investigación Biomédica de Málaga, Málaga, Spain
  • Genitourinary Cancer Translational Research Group, Instituto de Investigación Biomédica de Málaga, Málaga, Spain
  • Instituto de Investigación Biomédica de Málaga (ES)
  • Department of Pathology, Faculty of Medicine, Universidad de Málaga, Málaga, Spain
  • Department of Pathology, Unidad de Gestión Clínica de Patología, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Málaga, Spain
  • Hospital Clínico Universitario Virgen de la Victoria (ES)
  • Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands
  • Department of Genetics, Institut Curie, PSL Research University, Paris, France
  • Université Paris Sciences et Lettres (FR)
  • Erasmus MC (NL)
  • Department of Pathology, René Huguenin Curie Institute, Saint Cloud, Paris, France
Corresponding author
Weyerer, Veronika
Venue
Journal of Clinical Pathology
Publisher
BMJ
Published
2021-09-28
Volume
76
Issue
2
Pages
126-132
ISSN
  • 0021-9746 (ISSN-L)
  • 1472-4146
OpenAlex
W3204543246
Cited by
20
References
34
Citations by year
2026: 2 · 2025: 3 · 2024: 7 · 2023: 3 · 2022: 5
FWCI
2.50
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Pathology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by-nc)
  • OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (submittedVersion, cc-by-nc)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (cc-by)
Funders
  • Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the Friedrich-Alexander University Erlangen-Nürnberg
  • ERA-NET TRANSCAN
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
upper tract urothelial carcinoma, microsatellite instability, mismatch repair proteins, Lynch syndrome, concordance
MeSH terms
Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Colorectal Neoplasms, Hereditary Nonpolyposis, Humans, Colorectal Neoplasms, Microsatellite Repeats, Microsatellite Instability, DNA Mismatch Repair

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort. https://app.cochat.ai/papers/10.1136/jclinpath-2021-207855
The paper
Kullmann, F., Strissel, P. L., Strick, R., Stoehr, R., Eckstein, M., Bertz, S., Wullich, B., Sikic, D., Wach, S., Taubert, H., Olbert, P., Heers, H., Lara, M. F., Macias, M. L., Matas-Rico, E., Lozano, M. J., Prieto, D., Hierro, I., van Doeveren, T., . . . Weyerer, V. (2023). Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort. Journal of Clinical Pathology. https://doi.org/10.1136/jclinpath-2021-207855

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.